The strategic mission and objectives of the Medical Affairs Professional Society (MAPS) Insights Focus Area Working Group are to create a community that advances our role as fully integrated strategic business partners to promote the growth of Medical Affairs Professionals within the MA insights sector worldwide; to develop our Insights FAWG community within MAPS to become the premier global destination of choice for Insights MA Professionals; and to catalyze our individual personal leadership development and professional career advancement.
We will organize insights workshops for MAPS meetings in the North America, APAC (Asia Pacific – China/Japan), and EMEA (Europe, Middle-East, Asia) regions. We develop original content for webinars, podcasts, eLearning courses and white papers. In addition, the working group will periodically contribute cogent and timely content on the insights sector for the MAPS publication, Elevate magazine. Most importantly, we will provide a supportive resource for all insights Medical Affairs Professionals.
#1 Develop value-based insights framework for Medical Affairs:
- Highlight how Insights-related activities add value to the overall MA activities
- Highlight interconnectedness of all insights-related activities across organization
- Provide guidance on foundational requirements for insights activities in MA
#2 Create awareness around insights-related activities in MA:
- Establish continuity in insights-related activities during the MAPS meetings, and between the meeting
- Develop supporting materials to communicate the impact and value of insights-related activities to internal stakeholders
#3 Develop Subject Matter Experts for insights function within Medical Affairs (MA):
- Ensure continuous education on insights at the MAPS level and encourage participation of MAPS members
- Develop understanding and initiate implementation of appropriate metrics and analytics for MA generated insights
#4 Monitor development in the technology area focusing on insights collection, metrics and analytics: Proactively follow up developments in the digital area (eg, solution providers as well as technologies that enable virtual communications, processing of information, genuine AI to assimilate) and inform MAPS membership on new developments
#5 Monitor developments pertinent to insights activities post COVID 19: Identify and share with MAPS membership new trends in insights activities that have emerged during the COVID 19 pandemic
Senior Director, Insights and Training Global Lead Medical Communications
Medical Affairs Professional Society
Senior Director for US CV Field Teams
Medical Affairs Professional Society
Senior Director, Medical AffairsMedical Affairs Professional Society
Senior Director, Global Field Medical ExcellenceMedical Affairs Professional Society
Executive Director - External EngagementMedical Affairs Professional Society
Regional DirectorMedical Affairs Professional Society
Therapy Lead, VaccinesMedical Affairs Professional Society
Regional Liaison DirectorMedical Affairs Professional Society
Sr. Director, Field MedicalMedical Affairs Professional Society
Medical Science LiaisonMedical Affairs Professional Society
Enric Sabata Junyent
Global Process Owner for Medical Insights ManagementMedical Affairs Professional Society
Senior Vice President, Insight AnalyticsMedical Affairs Professional Society
Associate Director, Insights & TrainingMedical Affairs Professional Society
Head of Medical Affairs ExcellenceMedical Affairs Professional Society
DirectorMedical Affairs Professional Society
Senior Director, US Medical Science Liaison LeadMedical Affairs Professional Society
Resources Related to Insights
https://medicalaffairs.org/wp-content/uploads/2021/09/Impetus-podcast-2.png 321 845 Mary Gluckle https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Mary Gluckle2021-09-20 11:29:342021-09-20 11:29:34Moving Beyond Ad Boards: Asynchronous HCP Engagement Strategies
This podcast, sponsored by Impetus Digital, explores the opportunities and benefits of platforms that deliver asynchronous engagement, noting dramatic increases in HCP/KOL participation and cost-per-word.
https://medicalaffairs.org/wp-content/uploads/2021/08/LARVOL-PODCAST-Featured-Images-1.png 321 845 Mary Gluckle https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Mary Gluckle2021-08-25 09:29:412021-08-25 09:37:30How to Tell the Difference Between Insights and Observations in Medical Affairs
In this podcast sponsored by LARVOL, MAPS speaks with Medical Affairs experts on how to help actionable insights float to the top of the ocean of insights data.
https://medicalaffairs.org/wp-content/uploads/2020/07/Partner-Circle-August.-20-Kernel-Post-Webinar-WP-Image-1.png 321 845 Medical Affairs Professional Society https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Medical Affairs Professional Society2021-08-20 12:02:212021-08-27 17:35:403 Ways Medical Affairs Leaders can Start Using Social Media Insights Now
In this webinar, experts share real-life examples of how Medical Affairs can use social media insights to improve outcomes for customers and patients.
https://medicalaffairs.org/wp-content/uploads/2021/08/IQVIA-Podcast-3-Featured.png 321 845 Mary Gluckle https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Mary Gluckle2021-08-16 12:50:532021-08-20 12:57:22The Evolving use of Social Media in Medical Affairs
This podcast sponsored by IQVIA explores social media for insights and thought leader identification.
https://medicalaffairs.org/wp-content/uploads/2021/08/Insights-Medical-Access-Featured.png 321 845 Medical Affairs Professional Society https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Medical Affairs Professional Society2021-08-04 17:45:182021-09-09 10:52:16Using Medical Insights to Improve Medication Access
Through generation of Medical Insights, MA enhances its “third pillar” role within the pharmaceutical company and demonstrates value as a key driver in activities directly affecting patient outcomes.
https://medicalaffairs.org/wp-content/uploads/2021/07/IQVIA-podcast-1-featured-2.png 321 845 Mary Gluckle https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Mary Gluckle2021-07-21 09:14:162021-07-21 11:00:13Natural Language Processing for Medical Insights
MAPS speaks with Hywel Evans Director of the IQVIA Natural Language Processing Insights Hub about NLP to generate medical insights.
https://medicalaffairs.org/wp-content/uploads/2021/06/External-Ed-FAWG-Innovate-Featured.png 321 845 Medical Affairs Professional Society https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Medical Affairs Professional Society2021-06-24 13:53:532021-09-10 09:03:15MAPS Focus Area Working Group Charts the Future of External Education in Medical Affairs
MAPS speaks with External Education FAWG leaders about their Standards and Guidance resource and about recent changes and future directions of External Education.
https://medicalaffairs.org/wp-content/uploads/2021/06/Intro-Coaching-Featured.png 321 845 Medical Affairs Professional Society https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Medical Affairs Professional Society2021-06-23 07:52:192021-07-01 10:56:25Intro to Coaching in Medical Affairs
Placing more focus on self-development and knowledge acquisition is imperative for Medical Affairs professionals of tomorrow — making proper coaching crucial for MA leaders.
https://medicalaffairs.org/wp-content/uploads/2021/06/Partner-Circle-Webinar-TemplateFeatured-Image.jpg 320 845 Medical Affairs Professional Society https://medicalaffairs.org/wp-content/uploads/2021/06/MAPS-Logo_no-tagline.png Medical Affairs Professional Society2021-06-16 10:00:282021-08-13 11:44:02How COVID-19 Emergency Use Authorizations Impacted the Provision of Medical Information
This webinar will feature speakers from Eli Lilly and Company, Gilead, and Pfizer. They will come together to represent their experiences in establishing medical information strategy, content and operations for Emergency Use Authorization (EUA) products for the prevention and treatment of COVID-19.